Literature DB >> 9434230

Esophagitis dissecans superficialis and alendronate: case report.

R B Cameron1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9434230     DOI： 10.1016/s0016-5107(97)70018-x

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  6 in total

Review 1.  Iatrogenic esophagitis.

Authors:  A S Arora; J A Murray
Journal:  Curr Gastroenterol Rep       Date:  2000-06

Review 2.  Alendronate: an update of its use in osteoporosis.

Authors:  M Sharpe; S Noble; C M Spencer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Esophagitis Dissecans Superficialis: Clinical, Endoscopic, and Histologic Features.

Authors:  Phil A Hart; Ryan C Romano; Roger K Moreira; Karthik Ravi; Seth Sweetser
Journal:  Dig Dis Sci       Date:  2015-02-21       Impact factor: 3.199

Review 4.  Treating osteoporosis with bisphosphonates and addressing adherence: a review of oral ibandronate.

Authors:  Charles H Chesnut
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.

Authors:  David Y Graham
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

6.  IgG4-Related Esophageal Disease Presenting as Esophagitis Dissecans Superficialis With Chronic Strictures.

Authors:  Myriam Dumas-Campagna; Simon Bouchard; Genevieve Soucy; Mickael Bouin
Journal:  J Clin Med Res       Date:  2014-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.